Single-Dose ZTI-01 for Pediatric Patients. However, without clear information linking ZTI-01 to Acute Lymphoblastic Leukemia treatment within your description, I cannot confidently include "Acute Lymphoblastic Leukemia" as part of this clinical trial's title based solely on its presence on a layman condition list. If you have more details connecting ZTI-01 to leukemia treatment specifically, please provide them so I can give an accurate title (Pediatric_PK Trial)

"Currently, 6 trials of the ZTI-01 100 mg/kg drug exist in 14 cities and 5 countries. The original evaluation was completed by Nabriva Therapeutics AG back in 2018; 21 patients participated in Phase 1 of the trial before it received approval from authorities. Since then, 22 finished studies have been logged."

"The current recruitment efforts are focusing on 5 major medical centres, such as the Kosair Charities Pediatric Clinical Research Unit in Louisville and the Children's Hospital of Michigan in Detroit. Two other sites located in Orange County and multiple additional locations have also opened enrollment for this trial."

"Presently, there are six live clinical trials assessing the efficacy of ZTI-01 100 mg/kg. Technically, none of these investigations have advanced to Phase 3 yet; nevertheless they are conducted in 23 different sites with a majority being located in Albuquerque, New mexico."

"Affirmative, based on the clinicaltrials.gov portal, this medical trial is actively recruiting volunteers. It was first published on May 24th 2018 and last edited on March 3rd 2022; 21 patients are expected to be enrolled in total across 5 sites."

"Due to the limited data surrounding ZTI-01 100 mg/kg, its safety rating is 1 on a scale from 1 to 3. This assessment is based upon this medication's status as a Phase 1 trial without much prior evidence attesting its efficacy or security."

"Affirmative. The clinicaltrials.gov database indicates that the trial, which commenced on May 24th 2018, is currently accepting recruits. Twenty one individuals are required from 5 medical centres for enrollment in this study."